Brain+ AS (OCSE:BRAINP) EPS (Basic) : kr-0.50 (TTM As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Brain+ AS EPS (Basic)?

Brain+ AS's basic earnings per share (Basic EPS) for the six months ended in Dec. 2023 was kr-0.20. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Dec. 2023 was kr-0.50.

Brain+ AS's EPS (Diluted) for the six months ended in Dec. 2023 was kr-0.20. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was kr-0.50.

Brain+ AS's EPS without NRI for the six months ended in Dec. 2023 was kr-0.20. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Dec. 2023 was -0.50.

During the past 3 years, the average EPS without NRI Growth Rate was -85.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 5 years, Brain+ AS's highest 3-Year average EPS without NRI Growth Rate was -85.00% per year. The lowest was -109.40% per year. And the median was -97.20% per year.

Brain+ AS EPS (Basic) Historical Data

The historical data trend for Brain+ AS's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Brain+ AS EPS (Basic) Chart

Brain+ AS Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

EPS (Basic)

-0.09

-0.07

-0.89

-0.78

-0.52

Brain+ AS Semi-Annual Data
	Dec19	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
EPS (Basic)	Get a 7-Day Free Trial			-0.24	-0.35	-0.43	-0.30	-0.20

Brain+ AS EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Brain+ AS's Basic EPS for the fiscal year that ended in Dec. 2023 is calculated as

Basic EPS (A: Dec. 2023 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(-19.125	-	0)	/	36.721
	=	-0.52

Brain+ AS's Basic EPS for the quarter that ended in Dec. 2023 is calculated as

Basic EPS (Q: Dec. 2023 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(-13.051	-	0)	/	53.055
	=	-0.25

EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was kr-0.50

Brain+ AS (OCSE:BRAINP) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Brain+ AS EPS (Basic) Related Terms

Thank you for viewing the detailed overview of Brain+ AS's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.

Brain+ AS (OCSE:BRAINP) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Brain+ AS (OCSE:BRAINP) » Definitions » EPS (Basic)

Comparable Companies

Traded in Other Exchanges

N/A

Address

Kobmagergade 53, 3rd Floor, Copenhagen, DNK, DK-1150

Website

https://www.brain-plus.com

Brain+ AS is a digital therapeutics company. It restores patients' quality of life by treating and detecting a cognitive decline in Alzheimer's disease and dementia through digital means. It has developed a set of Digital Medicine technologies. Its product pipeline includes CST Therapist Companion, and CST Home Companion; CST Home Care; CST for Mild Cognitive Impairment (MCI).

Brain+ AS (OCSE:BRAINP) Headlines

No Headlines